论文部分内容阅读
目的:溃疡性结肠炎(Ulcerative Colitis,UC)是一种非特异性炎症性肠病,本文对比柳氮磺胺吡啶(SASP)口服和SASP口服加灌肠治疗溃疡性结肠炎的疗效。方法:按住院先后分为两组各12例,对照观察SASP口服和口服加灌肠对UC的治疗作用以及它们的副作用。结果:两组患者经20天治疗,无1例达到治愈标准。A组有效率为8/12(66.7%),B组有效率9/12(75%),两组比较P>0.05。结论:本组观察SASP口服和SASP口服加灌肠治疗溃疡性结肠炎有相近的疗效。然而口服SASP的副作用显然多于后者。
OBJECTIVE: Ulcerative colitis (UC) is a non-specific inflammatory bowel disease. In this paper, we compared the efficacy of oral administration of SASP and SASP in the treatment of ulcerative colitis. Methods: According to the hospital, divided into two groups of 12 cases, the control observed SASP oral and oral enema on the treatment of UC and their side effects. Results: Two groups of patients after 20 days of treatment, no one to cure standards. The effective rate was 8/12 (66.7%) in group A, 9/12 (75%) in group B, P> 0.05. Conclusion: This group observed SASP oral and SASP oral enema for the treatment of ulcerative colitis have a similar effect. However, the side effects of oral SASP is clearly more than the latter.